Article
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.
British journal of cancer - 1 Oct 2013
Gahr S, Stoehr R, Geissinger E, Ficker J H, Brueckl W M, Gschwendtner A, Gattenloehner S, Fuchs F S, Schulz C, Rieker R J, Hartmann A, Ruemmele P, Dietmaier W
Abstract excerpt
BACKGROUND: The prognosis of metastatic non-small cell lung cancer (NSCLC) is still poor. Activating epithelial growth factor receptor (EGFR) mutations are important genetic alterations with dramatic therapeutical implications. Up to now, in contrast to Asian populations only limited data on the prevalence of those mutations are available from patients with Caucasian and especially European ethnicity. METHODS: In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
